Effect of perioperative aspirin use on hemorrhagic complications in elective craniotomy for brain tumors: results of a single-center, retrospective cohort study

Hanalioglu Ş., Sahin B., Sahin O. S., Kozan A., Ucer M., Cikla U., ...Daha Fazla

JOURNAL OF NEUROSURGERY, cilt.132, sa.5, ss.1529-1538, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 132 Sayı: 5
  • Basım Tarihi: 2020
  • Doi Numarası: 10.3171/2018.12.jns182483
  • Dergi Adı: JOURNAL OF NEUROSURGERY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.1529-1538
  • Anahtar Kelimeler: aspirin, acetylsalicylic acid, hemorrhage, thromboembolism, brain tumor, craniotomy, vascular disorders, LOW-DOSE ASPIRIN, NONCARDIAC SURGERY, SPINAL SURGERY, BLOOD-LOSS, SUBDURAL-HEMATOMA, TASK-FORCE, ANTIPLATELET, MANAGEMENT, THERAPY, ANTICOAGULANT
  • Hacettepe Üniversitesi Adresli: Evet

Özet

OBJECTIVE In daily practice, neurosurgeons face increasing numbers of patients using aspirin (acetylsalicylic acid, ASA). While many of these patients discontinue ASA 7-10 days prior to elective intracranial surgery, there are limited data to support whether or not perioperative ASA use heightens the risk of hemorrhagic complications. In this study the authors retrospectively evaluated the safety of perioperative ASA use in patients undergoing craniotomy for brain tumors in the largest elective cranial surgery cohort reported to date.